We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Tools for Treatment of Peripheral Vascular Disease

By HospiMedica International staff writers
Posted on 03 Oct 2012
Two new devices offer an innovative endovascular approach to treating chronic total occlusions (CTOs) in peripheral arteries.

The Viance Crossing Catheter is designed to quickly and safely deliver a guidewire via the true lumen or subintimal pathways, utilizing finesse rather than force to cross. More...
With the aid of an atraumatic, low-profile tip, the device remains within the true lumen, allowing for more treatment options. In cases where the device tracks into the subintimal space, it creates a very small channel, helping to facilitate reliable re-entry. The multicoiled wire shaft results in 1:1 torque for predicable response, and a fast spin torque handle enables the physician to spin the device quickly to transfer torque.

The Enteer Re-entry System consists of a catheter and guidewire, enabling the physician to target reliably the true lumen from the subintimal channel, above or below the knee. The catheter's unique, flat shape self-orients in the subintimal space, helping to enable reentry without complete reliance on visualization. An angled reentry probe at the guidewire tip engages the intima to enter true lumen, and a unique balloon shape self-orients within the vessel for true lumen targeting; 180° opposed and offset exit ports enable selective guidewire reentry.

The Viance Crossing Catheter and the Enteer Re-entry System are products of Covidien (Dublin, Ireland), and are designed to enable access to the distal end of a lesion, allowing physicians to treat even the most challenging lesions endovascularly.

“Covidien now offers a unique solution for the treatment of CTOs,” said Brian Verrier, vice president and general manager of peripheral vascular products at Covidien. “By adding these products to our market-leading peripheral portfolio, we strive to demonstrate our commitment to advancing the treatment of vascular disease worldwide by delivering innovation that achieves both clinical and economic value for our healthcare partners.”

Related Links:

Covidien



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Monitor/Defibrillator
Zenix
New
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Health IT

view channel
Photo courtesy of Adobe Stock

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.